AXL and non-small cell lung carcinoma: Expression of AXL, another member of the TAM RTK family, has been previously correlated with resistance to OSI and other EGFR TKIs, and AXL inhibition restored sensitivity to EGFR TKIs in AXL-expressing EGFRMT NSCLC cells (31, 46, 47).